Kenvue Vaping Cessation Study: Nicorette QuickMist Provides ‘Significant And Fast’ Relief

Use of Kenvue’s Nicorette QuickMist nicotine replacement therapy device resulted in “statistically significant reductions in urges to vape as soon as 30 seconds and up to two hours after dosing compared with placebo,” according to a recently published study funded by the firm.